BioInvent International AB (publ) (STO:BINV)
4.310
-1.120 (-20.63%)
Nov 2, 2026, 4:23 PM CET
BioInvent International AB Employees
BioInvent International AB had 108 employees as of June 30, 2026. The number of employees decreased by 14 or 11.48% compared to the same quarter last year. That makes BioInvent International AB the 31,006th largest employer in the world and 358th in Sweden.
Employees
108
Change (1Y)
-14
Growth (1Y)
-11.48%
Revenue / Employee
370.20K SEK
Profits / Employee
-4.51M SEK
Market Cap
283.62M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 108 | -14 | -11.48% |
| Mar 31, 2026 | 112 | -6 | -5.08% |
| Dec 31, 2025 | 109 | -5 | -4.39% |
| Sep 30, 2025 | 124 | 9 | 7.83% |
| Jun 30, 2025 | 122 | 10 | 8.93% |
| Mar 31, 2025 | 118 | 9 | 8.26% |
| Dec 31, 2024 | 114 | 3 | 2.70% |
| Sep 30, 2024 | 115 | 7 | 6.48% |
| Jun 30, 2024 | 112 | 9 | 8.74% |
| Mar 31, 2024 | 109 | 7 | 6.86% |
| Dec 31, 2023 | 111 | 17 | 18.09% |
| Sep 30, 2023 | 108 | 15 | 16.13% |
| Jun 30, 2023 | 103 | 14 | 15.73% |
| Mar 31, 2023 | 102 | 16 | 18.60% |
| Dec 31, 2022 | 94 | 10 | 11.90% |
| Sep 30, 2022 | 93 | 8 | 9.41% |
| Jun 30, 2022 | 89 | 11 | 14.10% |
| Mar 31, 2022 | 86 | 12 | 16.22% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Oncopeptides AB | 69 |
| Sprint Bioscience AB | 32 |
| IRLAB Therapeutics AB | 31 |
| Xbrane Biopharma AB | 29 |
| Xspray Pharma AB | 24 |
| Cantargia AB | 22 |
| Mendus AB | 19 |
| Intervacc AB | 16 |
BioInvent International AB News
- 4 days ago - BioInvent International AB Earnings Call Transcript: Q3 2026 - Transcripts
- 4 days ago - BioInvent International AB Quarterly report: Q3 2026 - Filings
- 4 days ago - BioInvent International AB Slides: Q3 2026 - Filings
- 9 days ago - BioInvent's BI-1808 and KEYTRUDA(R) Induce Durable Responses in Heavily Pretreated Platinum-Resistant Ovarian Cancer - Accesswire
- 12 days ago - BioInvent International AB Slides: Corporate presentation - Filings
- 14 days ago - BioInvent To Present BI-1808 Data in Platinum-Resistant Recurrent Ovarian Cancer at ESMO 2026 - Accesswire
- 18 days ago - BioInvent Announces Publication of First-in-Human BI-1808 Data in Clinical Cancer Research - Accesswire
- 21 days ago - BioInvent International AB Announces that its CFO will Retire in 2027 - Accesswire